News Headlines Article

Pancreatic cancer treatment that almost never was lands key FDA win
San Francisco Business Times

Aduro BioTech Inc.’s immune system-boosting treatment for fighting deadly pancreatic cancer won “breakthrough therapy” designation from regulators, the small Berkeley company said Monday. The breakthrough therapy tag can accelerate approval of badly needed drugs from years to 60 days by speeding the Food and Drug Administration review of drugs that are a “substantial improvement” over existing therapies.